The scaffold protein p62 regulates adaptive thermogenesis through ATF2 nuclear target activation
During β-adrenergic stimulation of brown adipose tissue (BAT), p38 phosphorylates the activating transcription factor 2 (ATF2) which then translocates to the nucleus to activate the expression of Ucp1 and Pgc-1α . The mechanisms underlying ATF2 target activation are unknown. Here we demonstrate that...
Gespeichert in:
Veröffentlicht in: | Nature communications 2020-05, Vol.11 (1), p.2306-13, Article 2306 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | During β-adrenergic stimulation of brown adipose tissue (BAT), p38 phosphorylates the activating transcription factor 2 (ATF2) which then translocates to the nucleus to activate the expression of
Ucp1
and
Pgc-1α
. The mechanisms underlying ATF2 target activation are unknown. Here we demonstrate that p62 (Sqstm1) binds to ATF2 to orchestrate activation of the
Ucp1
enhancer and
Pgc-1α
promoter. P62
Δ69-251
mice show reduced expression of
Ucp1
and
Pgc-1α
with impaired ATF2 genomic binding. Modulation of
Ucp1
and
Pgc-1α
expression through p62 regulation of ATF2 signaling is demonstrated in vitro and in vivo in p62
Δ69-251
mice, global p62
−/−
and Ucp1-Cre p62
flx/flx
mice. BAT dysfunction resulting from p62 deficiency is manifest after birth and obesity subsequently develops despite normal food intake, intestinal nutrient absorption and locomotor activity. In summary, our data identify p62 as a master regulator of BAT function in that it controls the
Ucp1
pathway through regulation of ATF2 genomic binding.
Beta-adrenergic stimulation of brown adipose tissue leads to thermogenesis via the activating transcription factor 2 (ATF2) mediated expression of the thermogenic genes
Ucp1
and
Pgc-1α
. Here, the authors show that the scaffold protein p62 regulates brown adipose tissue function through modifying ATF2 genomic binding and subsequent
Ucp1
and
Pgc-1α
induction. |
---|---|
ISSN: | 2041-1723 2041-1723 |
DOI: | 10.1038/s41467-020-16230-8 |